Based on the nature of the pathologic process, biomarkers for AD can be classified into three main groups according to the AT(N) system (Jack et al., 2018): biomarkers of Aβ plaques (A), biomarkers of fibrillar tau (T), and biomarkers of neurodegeneration or neuronal injury (N). The gene discussed is MAPT; the disease is Alzheimer disease.